JBF Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

JBF Capital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-543,990	Closed	-$1.34M	–	111
2020 Q4	$1.34M	Buy	543,990 +393,212	+261%	+$957K	0.22%	14
2020 Q3	$475K	Buy	150,778 +100,053	+197%	+$320K	0.08%	34
2020 Q2	$148K	Buy	+50,725	New	+$160K	0.02%	59

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

JBF Capital's PDLI Position: Q1 2021 in Review

JBF Capital sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 543,990 shares — an estimated $1.34M sold.

JBF Capital first reported a position in PDLI in Q2 2020 and held it in 3 quarters. The position peaked at $1.34M in Q4 2020. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

JBF Capital reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
JBF Capital sold 543,990 PDL BioPharma, Inc. shares in Q1 2021, an estimated $1.34M.
JBF Capital first reported a position in PDL BioPharma, Inc. in Q2 2020 and held it in 3 quarters.
JBF Capital's PDL BioPharma, Inc. position peaked at $1.34M in Q4 2020.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on JBF Capital's 13F filing for Q1 2021, filed 13 May 2021.